Abstract
The incidence of malignant mesothelioma has increased greatly in the last 40 years. Current and recent past exposure to asbestos is expected to substantially increase this incidence. We report nine cases of malignant mesothelioma which temporarily responded to treatment with high‐dose methotrexate—citrovorum rescue and vincristine. Further clinical trials of high‐dose methotrexate with citrovorum rescue appear indicated in this disease. Copyright © 1982 American Cancer Society
Cite
CITATION STYLE
Dimitrov, N. V., Egner, J., Balcueva, E., & Suhrland, L. G. (1982). High‐dose methotrexate with citrovorum factor and vincristine in the treatment of malignant mesothelioma. Cancer, 50(7), 1245–1247. https://doi.org/10.1002/1097-0142(19821001)50:7<1245::AID-CNCR2820500704>3.0.CO;2-H
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
